Dee Anna Smith (@dee_anna_smith) 's Twitter Profile
Dee Anna Smith

@dee_anna_smith

CEO Sarah Cannon Research Institute | Today’s Clinical Trials. Tomorrow’s Therapies. #Oncology #Healthcare #ClinicalTrials

ID: 1481071776

linkhttp://www.scri.com calendar_today04-06-2013 01:53:10

522 Tweet

594 Takipçi

575 Takip Edilen

Sarah Cannon Docs (@sarahcannondocs) 's Twitter Profile Photo

Did you know that Sarah Cannon has the largest network providing hematopoietic cell transplants? Stop by booth number 2158 to find out how we’re advancing science and transforming care for blood cancer patients

Did you know that Sarah Cannon has the largest network providing hematopoietic cell transplants? Stop by booth number 2158 to find out how we’re advancing science and transforming care for blood cancer patients
Sarah Cannon Docs (@sarahcannondocs) 's Twitter Profile Photo

.Melissa L. Johnson is serving as this year’s ASCO® Scientific Committee Chair. Do not miss her discussion of “Cancer Care in the Time of COVID: Assessing Impact and Future Direction” today at 3:30PM CT

Multiple Myeloma Hub (@mm_hub) 's Twitter Profile Photo

PODCAST 🎧 Do you want to know the results of the CARTITUDE-1 study presented at #ASCO20? Listen to our podcast buff.ly/30rd3kK with Jesus Berdeja, Sarah Cannon Docs. #mmsm

PODCAST 🎧 Do you want to know the results of the CARTITUDE-1 study presented at #ASCO20? Listen to our podcast buff.ly/30rd3kK with Jesus Berdeja, <a href="/SarahCannonDocs/">Sarah Cannon Docs</a>. #mmsm
Dee Anna Smith (@dee_anna_smith) 's Twitter Profile Photo

This is a record ASCO for SCRI, with  135+ presentations, 64 early-phase study updates and 82 authors across the network late-phase study findings.  #ASCO23

Sarah Cannon Docs (@sarahcannondocs) 's Twitter Profile Photo

David R. Spigel, MD, FASCO presented important updates from the ADRIATIC study for limited stage #smallcelllungcancer #ASCO24 An exciting day in #lungcancer with results from LAURA study as well as ADRIATIC study, proving again that Today’s Clinical Trials are Tomorrow’s Therapies.

<a href="/DavidRSpigel/">David R. Spigel, MD, FASCO</a> presented important updates from the ADRIATIC study for limited stage #smallcelllungcancer #ASCO24

An exciting day in #lungcancer with results from LAURA study as well as ADRIATIC study, proving again that Today’s Clinical Trials are Tomorrow’s Therapies.
Dee Anna Smith (@dee_anna_smith) 's Twitter Profile Photo

Happy National Cancer Survivors Day. Today and every day, we celebrate the courage, perseverance and strength of survivors around the world. #NationalCancerSurvivorsDay #NCSD

Dee Anna Smith (@dee_anna_smith) 's Twitter Profile Photo

Practice Changing Trial Results for People Facing #LungCancer- led by our very own, Dr. David R. Spigel, MD, FASCO. Learn more about the new standard of care from Dr. Spigel and former patient, Matt, in the The Wall Street Journal wsj.com/health/healthc… Sarah Cannon Docs #ClinicalResearch

Dee Anna Smith (@dee_anna_smith) 's Twitter Profile Photo

We are excited about this new development for our long-standing research partners at Florida Cancer Specialists & Research Institute, as we continue to work together to advance drug development and bring innovative therapies to patients close to home.